Bryan C. Tan

1.9k total citations
15 papers, 491 citations indexed

About

Bryan C. Tan is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Bryan C. Tan has authored 15 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Bryan C. Tan's work include Lipid metabolism and biosynthesis (3 papers), Liver Disease Diagnosis and Treatment (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Bryan C. Tan is often cited by papers focused on Lipid metabolism and biosynthesis (3 papers), Liver Disease Diagnosis and Treatment (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Bryan C. Tan collaborates with scholars based in Singapore, United States and Australia. Bryan C. Tan's co-authors include David L. Silver, Yen Ching Lim, Zachary E. McPherson, Long N. Nguyen, Sven Pettersson, Agata Korecka, Dao‐Yi Yu, Vera J. Goh, Dong An and Chandrakumar Balaratnasingam and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Bryan C. Tan

14 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bryan C. Tan Singapore 12 261 104 93 85 78 15 491
Camila Martínez Calejman Argentina 13 294 1.1× 106 1.0× 290 3.1× 103 1.2× 131 1.7× 22 653
Agnieszka Mikłosz Poland 14 304 1.2× 63 0.6× 231 2.5× 44 0.5× 95 1.2× 41 587
Russell Watts Canada 11 295 1.1× 106 1.0× 151 1.6× 44 0.5× 162 2.1× 16 582
Baharan Fekry United States 14 287 1.1× 46 0.4× 141 1.5× 69 0.8× 74 0.9× 22 538
Ying Leng China 10 392 1.5× 64 0.6× 231 2.5× 39 0.5× 88 1.1× 19 575
Anfang Cui China 12 388 1.5× 54 0.5× 150 1.6× 131 1.5× 123 1.6× 15 614
Hyehun Choi United States 15 266 1.0× 35 0.3× 120 1.3× 46 0.5× 43 0.6× 25 512
Brandon M. Kenwood United States 11 329 1.3× 34 0.3× 173 1.9× 67 0.8× 142 1.8× 15 590
Sherwin Xie Singapore 7 200 0.8× 55 0.5× 99 1.1× 37 0.4× 273 3.5× 8 525
Arlene Lim United States 9 205 0.8× 51 0.5× 116 1.2× 27 0.3× 243 3.1× 10 612

Countries citing papers authored by Bryan C. Tan

Since Specialization
Citations

This map shows the geographic impact of Bryan C. Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan C. Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan C. Tan more than expected).

Fields of papers citing papers by Bryan C. Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan C. Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan C. Tan. The network helps show where Bryan C. Tan may publish in the future.

Co-authorship network of co-authors of Bryan C. Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan C. Tan. A scholar is included among the top collaborators of Bryan C. Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan C. Tan. Bryan C. Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Ohuchida, Kenoki, Bryan C. Tan, Yuki Shimada, et al.. (2025). Prognostic nutrition index reveals LAG3 in cytotoxic CD8+ T cells and MHC class II in gastric cancer cells. Cancer Immunology Immunotherapy. 74(6). 176–176.
2.
Zhang, Jinghui, Yusuke Mizuuchi, Kenoki Ohuchida, et al.. (2024). Exploring the tumor microenvironment of colorectal cancer patients post renal transplantation by single‐cell analysis. Cancer Science. 116(2). 500–512. 2 indexed citations
3.
Chin, Cheen Fei, Dwight L.A. Galam, Liang Gao, et al.. (2023). Blood-derived lysophospholipid sustains hepatic phospholipids and fat storage necessary for hepatoprotection in overnutrition. Journal of Clinical Investigation. 133(17). 12 indexed citations
4.
Tan, Bryan C., Cheen Fei Chin, Bernice H. Wong, et al.. (2023). Mfsd2a utilizes a flippase mechanism to mediate omega-3 fatty acid lysolipid transport. Proceedings of the National Academy of Sciences. 120(10). 28 indexed citations
5.
Chin, Cheen Fei, Liang Gao, Bernice H. Wong, et al.. (2023). Mfsd2a-mediated lysolipid transport is important for renal recovery after acute kidney injury. Journal of Lipid Research. 64(8). 100416–100416. 2 indexed citations
6.
Tan, Bryan C., Han Shi Jocelyn Chew, Rachel Sze Jen Goh, et al.. (2023). Efficacy and safety of tirzepatide for treatment of overweight or obesity. A systematic review and meta-analysis. International Journal of Obesity. 47(8). 677–685. 49 indexed citations
7.
Kuk, Alvin C. Y., Mei Ding, Cheen Fei Chin, et al.. (2022). Spns1 is a lysophospholipid transporter mediating lysosomal phospholipid salvage. Proceedings of the National Academy of Sciences. 119(40). e2210353119–e2210353119. 34 indexed citations
8.
Muthiah, Mark, Cheng Han Ng, Kai En Chan, et al.. (2022). Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis. Annals of Hepatology. 28(1). 100762–100762. 26 indexed citations
9.
An, Dong, Bryan C. Tan, Dao‐Yi Yu, & Chandrakumar Balaratnasingam. (2022). Differentiating Microaneurysm Pathophysiology in Diabetic Retinopathy Through Objective Analysis of Capillary Nonperfusion, Inflammation, and Pericytes. Diabetes. 71(4). 733–746. 31 indexed citations
10.
Lim, Yen Ching, Ufuk Degirmenci, Xiang Hu, et al.. (2020). The RNA-binding protein HuR is a negative regulator in adipogenesis. Nature Communications. 11(1). 213–213. 77 indexed citations
11.
McPherson, Zachary E., et al.. (2016). Host-microbiome interactions: the aryl hydrocarbon receptor and the central nervous system. Journal of Molecular Medicine. 95(1). 29–39. 48 indexed citations
12.
Goh, Vera J., Bryan C. Tan, Wei-Yi Ong, et al.. (2015). Postnatal Deletion of Fat Storage-inducing Transmembrane Protein 2 (FIT2/FITM2) Causes Lethal Enteropathy. Journal of Biological Chemistry. 290(42). 25686–25699. 33 indexed citations
13.
Miranda, Diego A., Long N. Nguyen, Cheng Wang, et al.. (2014). Fat Storage-inducing Transmembrane Protein 2 Is Required for Normal Fat Storage in Adipose Tissue. Journal of Biological Chemistry. 289(14). 9560–9572. 52 indexed citations
14.
Lu, Guo‐Dong, Jing Zhou, Benedict Yan, et al.. (2014). CCAAT/enhancer binding protein α predicts poorer prognosis and prevents energy starvation–induced cell death in hepatocellular carcinoma. Hepatology. 61(3). 965–978. 75 indexed citations
15.
Tarulli, Gerard A., et al.. (2013). Hormone-sensing cells require Wip1 for paracrine stimulation in normal and premalignant mammary epithelium. Breast Cancer Research. 15(1). R10–R10. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026